Ian Mortimer
Director, PRESIDENT & CEO · 2 filings · Latest: Mar 12, 2026
Xenon Pharmaceuticals Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
XENE | Ian Mortimer | Director, PRESIDENT & CEO | Mar 13, 2026 | Sale | $55.23 | 7,308 | $403.6K | 19,923 | |
XENE | Ian Mortimer | Director, PRESIDENT & CEO | Mar 12, 2026 | Option Exercise | — | 12,500 | — | 27,231 | |
XENE | Ian Mortimer | Director, PRESIDENT & CEO | Mar 10, 2026 | Sale | $60.11 | 11,269 | $677.4K | 14,731 | |
XENE | Ian Mortimer | Director, PRESIDENT & CEO | Mar 9, 2026 | Sale | $60.33 | 270,000 | $16.3M | 6,000 | |
XENE | Ian Mortimer | Director, PRESIDENT & CEO | Mar 9, 2026 | Option Exercise | $6.28 | 290,000 | $1.8M | 26,000 |